$LOAN
MANHATTAN BRIDGE CAPITAL, INC Stock $loan

$loan Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000149315223007249 Filed on March 10, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$2.398M	$2.232M	$8.571M
YoY Change	13.37%	28.45%	25.9%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$496.1K	$424.1K	$1.549M
YoY Change	37.24%	16.2%	14.86%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$892.00	$710.00	$2.307K
YoY Change	89.79%	29.09%	1.63%
% of Gross Profit
Operating Expenses	$496.4K	$424.6K	$1.554M
YoY Change	36.8%	16.01%	14.55%
Operating Profit	$1.255M		$5.194M
YoY Change	-11.63%		17.89%
Interest Expense	-$646.3K	-$617.9K	-$1.823M
YoY Change	94.74%	172.75%	74.34%
% of Operating Profit	-51.49%		-35.09%
Other Income/Expense, Net	$4.500K	$4.500K	$18.00K
YoY Change	0.0%	0.0%	0.0%
Pretax Income	$1.260M	$1.194M	$5.212M
YoY Change	-11.6%	3.86%	17.82%
Income Tax		$0.00	$650.00
% Of Pretax Income		0.0%	0.01%
Net Earnings	$1.260M	$1.194M	$5.212M
YoY Change	-11.6%	3.86%	17.82%
Net Earnings / Revenue	52.53%	53.5%	60.81%
Basic Earnings Per Share	$0.11		$0.45
Diluted Earnings Per Share	$0.11	$0.10	$0.45
COMMON SHARES
Basic Shares Outstanding	11.49M shares	11.49M shares	11.49M shares
Diluted Shares Outstanding	11.49M shares		11.49M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$75.19K	$103.5K	$103.5K
YoY Change	-48.28%	-27.37%	-27.37%
Cash & Equivalents	$75.19K	$103.5K	$103.5K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$73.28M	$75.95M	$75.95M
YoY Change	5.27%	13.68%	13.68%
LONG-TERM ASSETS
Property, Plant & Equipment	$248.5K	$262.2K	$262.2K
YoY Change	-18.08%	-17.3%	-17.3%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$136.1K	$67.27K	$67.27K
YoY Change	2.57%	-10.64%	-10.64%
Total Long-Term Assets	$384.6K	$329.5K	$329.5K
YoY Change	-11.8%	-16.02%	-16.03%
TOTAL ASSETS
Total Short-Term Assets	$73.28M	$75.95M	$75.95M
Total Long-Term Assets	$384.6K	$329.5K	$329.5K
Total Assets	$73.67M	$76.28M	$76.28M
YoY Change	5.17%	13.5%	13.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$261.8K	$289.9K	$289.9K
YoY Change	76.66%	88.02%	88.02%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.206M	$2.396M	$2.396M
YoY Change	-2.97%	10.33%	10.33%
LONG-TERM LIABILITIES
Long-Term Debt	$28.35M	$30.75M	$30.75M
YoY Change	17.71%	44.19%	44.19%
Other Long-Term Liabilities	$278.0K	$273.5K	$273.5K
YoY Change	-10.84%	-15.65%	-15.65%
Total Long-Term Liabilities	$28.63M	$31.02M	$31.02M
YoY Change	17.35%	43.3%	43.3%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.206M	$2.396M	$2.396M
Total Long-Term Liabilities	$28.63M	$31.02M	$31.02M
Total Liabilities	$30.84M	$33.42M	$33.42M
YoY Change	15.61%	40.29%	40.29%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.919M	-$1.885M
YoY Change		39.7%
Common Stock	$11.76K	$11.76K
YoY Change		0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$798.9K	$798.9K
YoY Change		0.0%
Treasury Stock Shares		262.1K shares
Shareholders Equity	$42.83M	$42.86M	$42.86M
YoY Change
Total Liabilities & Shareholders Equity	$73.67M	$76.28M	$76.28M
YoY Change	5.17%	13.5%	13.5%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	$1.260M	$1.194M	$5.212M
YoY Change	-11.6%	3.86%	17.82%
Depreciation, Depletion And Amortization	$892.00	$710.00	$2.307K
YoY Change	89.79%	29.09%	1.63%
Cash From Operating Activities	$1.315M	$1.148M	$5.167M
YoY Change	-9.62%	-20.8%	12.34%
INVESTING ACTIVITIES
Capital Expenditures	$5.085K	$980.00	$2.871K
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$2.551M	-$1.782M	-$8.768M
YoY Change	-193.68%	-85.32%	15.11%
Cash From Investing Activities	$2.546M	-$1.783M	-$8.771M
YoY Change	-193.49%	-85.32%	15.14%
FINANCING ACTIVITIES
Cash Dividend Paid	$1.437M		$5.747M
YoY Change	0.0%		15.18%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$3.889M	195.8K	$3.565M
YoY Change	-406.0%	-98.17%	31.97%
NET CHANGE
Cash From Operating Activities	$1.315M	1.148M	$5.167M
Cash From Investing Activities	$2.546M	-1.783M	-$8.771M
Cash From Financing Activities	-$3.889M	195.8K	$3.565M
Net Change In Cash	-$28.35K	-439.4K	-$39.01K
YoY Change	-1105.25%	-1437.31%	-87.68%
FREE CASH FLOW
Cash From Operating Activities	$1.315M	$1.148M	$5.167M
Capital Expenditures	$5.085K	$980.00	$2.871K
Free Cash Flow	$1.310M	$1.147M	$5.164M
YoY Change	-9.97%	-20.87%	12.28%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001080340
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
CY2022	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		usd
CY2021	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts		usd
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	000-25991
CY2022	dei	Entity Registrant Name EntityRegistrantName	MANHATTAN BRIDGE CAPITAL, INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NY
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	11-3474831
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	60 Cutter Mill Road
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 205
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Great Neck
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	11021
CY2022	dei	City Area Code CityAreaCode	(516)
CY2022	dei	Local Phone Number LocalPhoneNumber	444-3400
CY2022	dei	Security12b Title Security12bTitle	Common Stock, par value $.001 per share
CY2022	dei	Trading Symbol TradingSymbol	LOAN
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	48770635	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	11494945	shares
CY2022	dei	Auditor Firm AuditorFirmId	694
CY2022	dei	Auditor Name AuditorName	Hoberman & Lesser, CPA’s LLP
CY2022	dei	Auditor Location AuditorLocation	New York
CY2022Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	74483463	usd
CY2021Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	65715364	usd
CY2022Q4	us-gaap	Interest Receivable InterestReceivable	1363502	usd
CY2021Q4	us-gaap	Interest Receivable InterestReceivable	955443	usd
CY2022Q4	us-gaap	Cash Cash	103540	usd
CY2021Q4	us-gaap	Cash Cash	142546	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	59566	usd
CY2021Q4	us-gaap	Other Assets OtherAssets	64745	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	262222	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	317080	usd
CY2022Q4	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	7708	usd
CY2021Q4	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	10539	usd
CY2022Q4	us-gaap	Assets Assets	76280001	usd
CY2021Q4	us-gaap	Assets Assets	67205717	usd
CY2022Q4	us-gaap	Line Of Credit LineOfCredit	24994234	usd
CY2021Q4	us-gaap	Line Of Credit LineOfCredit	15645970	usd
CY2022Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	247155	usd
CY2021Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	322241	usd
CY2022Q4	us-gaap	Secured Debt SecuredDebt	5752845	usd
CY2021Q4	us-gaap	Secured Debt SecuredDebt	5677759	usd
CY2022Q4	LOAN	Deferred Origination Fees DeferredOriginationFees	669128	usd
CY2021Q4	LOAN	Deferred Origination Fees DeferredOriginationFees	580461	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	289868	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	154169	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	273485	usd
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	324248	usd
CY2022Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	1436868	usd
CY2021Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	1436868	usd
CY2022Q4	us-gaap	Liabilities Liabilities	33416428	usd
CY2021Q4	us-gaap	Liabilities Liabilities	23819475	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	11757058	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	11757058	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	11494945	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	11494945	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	11757	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	11757	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	45535811	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	45522746	usd
CY2022Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	262113	shares
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	262113	shares
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	798939	usd
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	798939	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1885056	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1349322	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	42863573	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	43386242	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	76280001	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	67205717	usd
CY2022	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	6772889	usd
CY2021	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	5608660	usd
CY2022	LOAN	Origination Fees OriginationFees	1798075	usd
CY2021	LOAN	Origination Fees OriginationFees	1199230	usd
CY2022	us-gaap	Revenues Revenues	8570964	usd
CY2021	us-gaap	Revenues Revenues	6807890	usd
CY2022	LOAN	Interest And Amortization Of Deferred Financing Costs InterestAndAmortizationOfDeferredFinancingCosts	1822825	usd
CY2021	LOAN	Interest And Amortization Of Deferred Financing Costs InterestAndAmortizationOfDeferredFinancingCosts	1045548	usd
CY2022	LOAN	Referral Fees ReferralFees	4500	usd
CY2021	LOAN	Referral Fees ReferralFees	7532	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1549251	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1348838	usd
CY2022	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	3376576	usd
CY2021	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	2401918	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	5194388	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	4405972	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	18000	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	18000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	5212388	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	4423972	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	650	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	647	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	5211738	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	4423325	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.45
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.42
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.45
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.42
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11494945	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10524055	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11494945	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10524055	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	31964190	usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	12354460	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	13065	usd
CY2021	us-gaap	Dividends Common Stock DividendsCommonStock	3931930	usd
CY2021	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend	1436868	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	4423325	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	43386242	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	13065	usd
CY2022	us-gaap	Dividends Common Stock DividendsCommonStock	4310604	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend	1436868	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	5211738	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	42863573	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	5211738	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	4423325	usd
CY2022	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	113736	usd
CY2021	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	87353	usd
CY2022	us-gaap	Depreciation Depreciation	2307	usd
CY2021	us-gaap	Depreciation Depreciation	2265	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	13065	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	13065	usd
CY2022	LOAN	Adjustment To Operating Lease Rightofuse Asset And Liability AdjustmentToOperatingLeaseRightofuseAssetAndLiability	4096	usd
CY2021	LOAN	Adjustment To Operating Lease Rightofuse Asset And Liability AdjustmentToOperatingLeaseRightofuseAssetAndLiability	3960	usd
CY2022	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	408059	usd
CY2021	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	128207	usd
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-5742	usd
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	443	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	135699	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-14771	usd
CY2022	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	-88667	usd
CY2021	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	-212823	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	5166991	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	4599370	usd
CY2022	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	60915596	usd
CY2021	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	49267892	usd
CY2022	us-gaap	Proceeds From Collection Of Loans Receivable ProceedsFromCollectionOfLoansReceivable	52147497	usd
CY2021	us-gaap	Proceeds From Collection Of Loans Receivable ProceedsFromCollectionOfLoansReceivable	41650498	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2871	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-8770970	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-7617394	usd
CY2021	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	12354460	usd
CY2022	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	9348264	usd
CY2021	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-4662903	usd
CY2022	us-gaap	Payments Of Dividends PaymentsOfDividends	5747472	usd
CY2021	us-gaap	Payments Of Dividends PaymentsOfDividends	4990124	usd
CY2022	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	35819	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3564973	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2701433	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-39006	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-316591	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	142546	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	459137	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	103540	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	142546	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	650	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	647	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	1581935	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	982491	usd
CY2022	LOAN	Operating Leases Paid During Period OperatingLeasesPaidDuringPeriod	63621	usd
CY2021	LOAN	Operating Leases Paid During Period OperatingLeasesPaidDuringPeriod	63481	usd
CY2022	LOAN	Dividend Declared And Payable DividendDeclaredAndPayable	1436868	usd
CY2021	LOAN	Dividend Declared And Payable DividendDeclaredAndPayable	1436868	usd
CY2021Q1	us-gaap	Restricted Cash RestrictedCash	327483	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_840_eus-gaap--UseOfEstimates_ziP4PqRtRcL" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_860_z68bdimLYbuc">Use of Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management will base the use of estimates on (a) a preset number of assumptions that consider past experience, (b) future projections, and (c) general financial market conditions. Actual amounts could differ from those estimates. <i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_842_eus-gaap--ConcentrationRiskCreditRisk_zzXiXAayIsF3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_867_zUDYT4y7aMZ2">Concentrations of Credit Risk</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and short term commercial loans.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company maintains its cash with two major financial institutions. Accounts at the financial institutions are insured by the Federal Deposit Insurance Corporation up to $<span id="xdx_902_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_c20221231_zD2f9wflBMY4" title="Cash, FDIC insured amount">250,000</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Credit risks associated with short term commercial loans the Company makes to real estate investors and related interest receivable are described in Note 4.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2022	LOAN	Reit Percentage Of Income Tax ReitPercentageOfIncomeTax	0.90	pure
CY2022	LOAN	Reit Remaining Percentage Of Income Tax ReitRemainingPercentageOfIncomeTax	0.10	pure
CY2022	us-gaap	Debt Instrument Term DebtInstrumentTerm	P1Y
CY2022Q4	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	60915596	usd
CY2021Q4	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	49267892	usd
CY2022	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	52147497	usd
CY2021	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	41650498	usd
CY2022	LOAN	Short Term Loans Receivable Limitation On Face Amount Description ShortTermLoansReceivableLimitationOnFaceAmountDescription	(i) 9.9% of the aggregate amount of our loan portfolio (not including the loan under consideration) and (ii) $3.5 million.
CY2022	LOAN	Short Term Loans Receivable Loantovalue Ratio ShortTermLoansReceivableLoantovalueRatio	In the case of acquisition financing, the principal amount of the loan usually does not exceed 75% of the value of the property (as determined by an independent appraiser), and in the case of construction financing, up to 80% of construction costs.
CY2020Q4	us-gaap	Lessee Operating Lease Description LesseeOperatingLeaseDescription	the Lease Amendment provides for gradual rent increases from approximately $4,500 per month during the first three years to $5,100 per month during the last year of the extension term.
CY2022Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	74483463	usd
CY2021Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	65715364	usd
CY2022Q4	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	24994234	usd
CY2022	LOAN	Agency Fee Percentage AgencyFeePercentage	0.005	pure
CY2022Q4	LOAN	Line Of Credit Facility Interest Rate Percentage LineOfCreditFacilityInterestRatePercentage	0.0839	pure
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	13065	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	13065	usd
CY2022	LOAN	Stock Issued During Period Shares Remaining Restricted Stock Award StockIssuedDuringPeriodSharesRemainingRestrictedStockAward	1000000	shares
CY2022Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	47904	usd
CY2020Q4	LOAN	Operating Lease Term Of Lease OperatingLeaseTermOfLease	extend the term of the lease through November 30, 2027
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	63326	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	61526	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	60926	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	60926	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	55848	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	302552	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	29067	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	273485	usd
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y10M17D
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0416	pure
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	63000	usd
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	63000	usd

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001493152-23-007249-index-headers.html	Edgar Link	pending
0001493152-23-007249-index.html	Edgar Link	pending
0001493152-23-007249.txt	Edgar Link	pending
0001493152-23-007249-xbrl.zip	Edgar Link	pending
ex10-15.htm	Edgar Link	pending
ex10-15_001.jpg	Edgar Link	pending
ex10-16.htm	Edgar Link	pending
ex10-16_001.jpg	Edgar Link	pending
ex23-1.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
fin_001.jpg	Edgar Link	pending
fin_002.jpg	Edgar Link	pending
fin_003.jpg	Edgar Link	pending
form10-k.htm	Edgar Link	pending
form10-k_001.jpg	Edgar Link	pending
loan-20221231.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
loan-20221231_cal.xml	Edgar Link	unprocessable
loan-20221231_def.xml	Edgar Link	unprocessable
loan-20221231_lab.xml	Edgar Link	unprocessable
loan-20221231_pre.xml	Edgar Link	unprocessable
form10-k_htm.xml	Edgar Link	completed
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LOAN
MANHATTAN BRIDGE CAPITAL, INC Stock $loan

2023 Q1 Form 10-K Financial Statement

#000149315223007249 Filed on March 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LOAN MANHATTAN BRIDGE CAPITAL, INC Stock $loan

2023 Q1 Form 10-K Financial Statement

#000149315223007249 Filed on March 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LOAN
MANHATTAN BRIDGE CAPITAL, INC Stock $loan